Clinical Trial Update: A Study to Evaluate Drug-Drug Interaction of TQ05105 Tablets [Phase 1]

View source ↗

Summary

The Phase 1 study evaluating drug-drug interactions of TQ05105 tablets has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• TQ05105

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Myelofibrosis | Phase 1 | Status: COMPLETED